Knockdown of CD82 resulted in decreased phosphorylation of AKT and reduced expression of BCL2L12, which leads to increased apoptosis of AML cells and inhibited colony formation of AML LSCs (Nishioka et al., 2015). Here, BCL2L12 is linked to acute myeloid leukemia.